| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.704 | 0.005 | 0.728 | DNA synthesis inhibitor | 0.728 0.004 DBMET00631 0.593 0.008 DBMET00982 | DBMET00631 | |
| 0.622 | 0.016 | 0.638 | Antibacterial | 0.638 0.014 DBMET00631 0.512 0.037 DBMET00982 | DBMET00631 | |
| 0.512 | 0.006 | 0.524 | Topoisomerase II inhibitor | 0.524 0.006 DBMET00631 0.396 0.01 DBMET00982 | DBMET00631 | |
| 0.337 | 0.033 | 0.353 | Interleukin agonist | 0.353 0.028 DBMET00631 0.237 0.088 DBMET00982 | DBMET00631 | |
| 0.271 | 0.004 | 0.278 | DNA gyrase inhibitor | 0.278 0.004 DBMET00631 0.21 0.005 DBMET00982 | DBMET00631 | |
| 0.377 | 0.122 | 0.409 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.409 0.092 DBMET00631 | DBMET00631 | |
| 0.261 | 0.014 | 0.261 | Cell wall synthesis inhibitor | 0.257 0.015 DBMET00631 0.185 0.037 DBMET00982 | ||
| 0.311 | 0.118 | 0.311 | Histamine release inhibitor | 0.224 0.176 DBMET00631 | ||
| 0.202 | 0.022 | 0.214 | Ferrochelatase inhibitor | 0.214 0.019 DBMET00631 0.125 0.05 DBMET00982 | DBMET00631 | |
| 0.178 | 0.006 | 0.178 | Autotaxin inhibitor | 0.149 0.008 DBMET00631 0.064 0.026 DBMET00982 | ||
| 0.181 | 0.014 | 0.181 | Creatine kinase inhibitor | 0.148 0.025 DBMET00631 0.152 0.023 DBMET00982 | ||
| 0.164 | 0.004 | 0.186 | DNA gyrase subunit B inhibitor | 0.186 0.003 DBMET00631 0.061 0.008 DBMET00982 | DBMET00631 | |
| 0.143 | 0.009 | 0.143 | HIV-1 integrase inhibitor | 0.134 0.011 DBMET00631 0.078 0.04 DBMET00982 | ||
| 0.138 | 0.005 | 0.23 | Topoisomerase II beta inhibitor | 0.23 0.004 DBMET00631 0.114 0.008 DBMET00982 | DBMET00631 | |
| 0.117 | 0.003 | 0.125 | DNA gyrase subunit A inhibitor | 0.125 0.003 DBMET00631 0.103 0.004 DBMET00982 | DBMET00631 | |
| 0.15 | 0.036 | 0.15 | GABA receptor agonist | 0.128 0.05 DBMET00631 0.127 0.051 DBMET00982 | ||
| 0.168 | 0.063 | 0.168 | Cytidine deaminase inhibitor | |||
| 0.141 | 0.045 | 0.141 | Topoisomerase I inhibitor | 0.141 0.045 DBMET00631 0.102 0.068 DBMET00982 | ||
| 0.087 | 0.004 | 0.11 | DNA topoisomerase IV inhibitor | 0.11 0.004 DBMET00631 0.068 0.004 DBMET00982 | DBMET00631 | |
| 0.094 | 0.019 | 0.094 | Protein kinase C eta inhibitor | 0.085 0.022 DBMET00631 | ||
| 0.208 | 0.136 | 0.208 | Gastrin inhibitor | |||
| 0.103 | 0.035 | 0.103 | GABA A receptor agonist | 0.1 0.038 DBMET00631 | ||
| 0.149 | 0.081 | 0.166 | Hexokinase inhibitor | 0.166 0.062 DBMET00631 | DBMET00631 | |
| 0.117 | 0.059 | 0.161 | DNA intercalator | 0.111 0.064 DBMET00631 0.161 0.038 DBMET00982 | DBMET00982 | |
| 0.084 | 0.028 | 0.084 | 5 Hydroxytryptamine 3A antagonist | 0.07 0.041 DBMET00631 | ||
| 0.103 | 0.047 | 0.103 | Protein kinase C zeta inhibitor | 0.097 0.054 DBMET00631 | ||
| 0.08 | 0.027 | 0.08 | Glutamate (mGluR7) antagonist | |||
| 0.116 | 0.067 | 0.116 | Transcription factor STAT6 inhibitor | 0.112 0.075 DBMET00631 | ||
| 0.169 | 0.122 | 0.169 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.114 | 0.068 | 0.114 | 5 Hydroxytryptamine antagonist | |||
| 0.054 | 0.013 | 0.054 | Acid-sensing ion channel blocker | 0.05 0.016 DBMET00631 0.046 0.02 DBMET00982 | ||
| 0.135 | 0.094 | 0.135 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 DBMET00982 | ||
| 0.153 | 0.113 | 0.159 | Psychostimulant | 0.159 0.109 DBMET00631 | DBMET00631 | |
| 0.086 | 0.046 | 0.086 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.075 0.055 DBMET00982 | ||
| 0.081 | 0.042 | 0.081 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.135 | 0.098 | 0.135 | Heat shock protein 70 antagonist | |||
| 0.106 | 0.069 | 0.106 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.074 | 0.04 | 0.074 | Protein kinase C beta inhibitor | 0.074 0.039 DBMET00631 | ||
| 0.144 | 0.115 | 0.144 | Lipocortins synthesis antagonist | 0.136 0.128 DBMET00982 | ||
| 0.116 | 0.087 | 0.126 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.126 0.079 DBMET00631 | DBMET00631 | |
| 0.039 | 0.011 | 0.039 | Protein kinase C beta I inhibitor | 0.037 0.013 DBMET00631 | ||
| 0.17 | 0.145 | 0.172 | DNA damaging | 0.172 0.143 DBMET00631 | DBMET00631 | |
| 0.055 | 0.03 | 0.055 | Phosphodiesterase 7A inhibitor | 0.053 0.033 DBMET00631 | ||
| 0.06 | 0.036 | 0.06 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.124 | 0.103 | 0.124 | Acetylcholine M1 receptor antagonist | |||
| 0.132 | 0.111 | 0.132 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.134 | 0.114 | 0.134 | Dual specificity phosphatase inhibitor | |||
| 0.095 | 0.075 | 0.095 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.077 | 0.057 | 0.077 | MAP kinase 7 inhibitor | |||
| 0.087 | 0.069 | 0.108 | Alcohol dehydrogenase inhibitor | 0.108 0.045 DBMET00631 | DBMET00631 | |
| 0.031 | 0.013 | 0.034 | DNA polymerase III inhibitor | 0.034 0.009 DBMET00631 | DBMET00631 | |
| 0.189 | 0.174 | 0.189 | Nootropic | |||
| 0.08 | 0.066 | 0.08 | Acetylcholine agonist | |||
| 0.142 | 0.128 | 0.143 | MAP kinase kinase 2 inhibitor | 0.143 0.128 DBMET00631 | DBMET00631 | |
| 0.037 | 0.024 | 0.037 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.058 | 0.046 | 0.061 | Cyclin D1 inhibitor | 0.061 0.04 DBMET00631 | DBMET00631 | |
| 0.208 | 0.198 | 0.208 | GABA C receptor rho-3 antagonist | |||
| 0.166 | 0.155 | 0.178 | MAP-kinase-activated kinase 5 inhibitor | 0.178 0.136 DBMET00631 | DBMET00631 | |
| 0.015 | 0.005 | 0.017 | DNA polymerase III polC-type inhibitor | 0.017 0.004 DBMET00631 0.013 0.01 DBMET00982 | DBMET00631 | |
| 0.041 | 0.031 | 0.063 | Dopamine D5 antagonist | 0.063 0.018 DBMET00982 | DBMET00982 | |
| 0.066 | 0.06 | 0.104 | Porphobilinogen synthase inhibitor | 0.104 0.034 DBMET00631 | DBMET00631 | |
| 0.093 | 0.089 | 0.094 | Protein kinase C gamma inhibitor | 0.094 0.088 DBMET00631 | DBMET00631 | |
| 0.082 | 0.078 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.031 | 0.027 | 0.034 | Protein kinase C beta II inhibitor | 0.034 0.019 DBMET00631 | DBMET00631 | |
| 0.048 | 0.046 | 0.048 | Acetylcholine muscarinic agonist | |||
| 0.002 | 0.001 | 0.002 | Antibiotic Rifamycin-like | |||
| 0.032 | 0.035 | 0.035 | Cyclin D3 inhibitor | 0.035 0.031 DBMET00631 | DBMET00631 | |
| 0.05 | 0.054 | 0.055 | Cyclin-dependent kinase 6 inhibitor | 0.055 0.047 DBMET00631 | DBMET00631 | |
| 0.073 | 0.088 | 0.099 | Protein kinase C delta inhibitor | 0.099 0.053 DBMET00631 | DBMET00631 | |
| 0.052 | 0.068 | 0.058 | Ryanodine receptor antagonist | 0.058 0.044 DBMET00631 | DBMET00631 | |
| 0.093 | 0.113 | 0.136 | Glycogen synthase kinase-3 alpha inhibitor | 0.136 0.075 DBMET00631 | DBMET00631 | |
| 0.072 | 0.095 | 0.083 | Triose-phosphate isomerase inhibitor | 0.083 0.071 DBMET00631 | DBMET00631 | |
| 0.187 | 0.213 | 0.197 | Interleukin 2 agonist | 0.197 0.194 DBMET00631 | DBMET00631 | |
| 0.095 | 0.123 | 0.111 | Ribosomal protein S6 kinase inhibitor | 0.111 0.101 DBMET00631 | DBMET00631 | |
| 0.052 | 0.083 | 0.066 | Protein kinase C alpha inhibitor | 0.066 0.051 DBMET00631 | DBMET00631 | |
| 0.034 | 0.071 | 0.06 | 5 Hydroxytryptamine 2 agonist | 0.06 0.027 DBMET00631 | DBMET00631 | |
| 0.21 | 0.257 | 0.317 | Calcium channel L-type activator | 0.317 0.143 DBMET00631 0.235 0.222 DBMET00982 | DBMET00631 | |
| 0.065 | 0.124 | 0.091 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 DBMET00631 | DBMET00631 | |
| 0.031 | 0.108 | 0.065 | 5 Hydroxytryptamine 2A agonist | 0.065 0.042 DBMET00631 | DBMET00631 | |
| 0.031 | 0.108 | 0.052 | Myc inhibitor | 0.052 0.041 DBMET00631 | DBMET00631 | |
| 0.028 | 0.118 | 0.058 | 5 Hydroxytryptamine agonist | 0.058 0.057 DBMET00631 | DBMET00631 | |
| 0.012 | 0.107 | 0.073 | 5 Hydroxytryptamine 2C agonist | 0.073 0.014 DBMET00631 | DBMET00631 | |
| 0.089 | 0.2 | 0.13 | Polo-like kinase-3 inhibitor | 0.13 0.11 DBMET00982 | DBMET00982 | |
| 0.049 | 0.187 | 0.105 | GABA C receptor agonist | 0.105 0.062 DBMET00631 | DBMET00631 | |
| 0.028 | 0.203 | 0.074 | Phospholipase D inhibitor | 0.074 0.044 DBMET00631 | DBMET00631 | |
| 0.102 | 0.291 | 0.168 | Superoxide dismutase inhibitor | 0.168 0.158 DBMET00631 | DBMET00631 | |
| 0.101 | 0.331 | 0.227 | Angiogenesis inhibitor | 0.227 0.141 DBMET00982 | DBMET00982 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |